Delirium Secondary to Lamotrigine Toxicity

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Medicine

Background:

• Lamotrigine, a phenyltriazine, is FDA-approved for seizure disorder and bipolar disorder.
• While generally well-tolerated, lamotrigine can cause severe side effects like rashes and multi-organ failure.
• Mental status changes are a known adverse effect, particularly with concurrent medications affecting lamotrigine metabolism.

Observation:

• A 65-year-old male on lamotrigine and valproic acid developed mental status changes.
• These changes emerged after the addition of sertraline to his medication regimen.
• This case is compared to existing literature on lamotrigine-induced adverse effects.

Findings:

• Adverse medication effects can manifest even with lamotrigine levels within the therapeutic range.
• Clinical correlation is crucial when interpreting medication levels.
• Normal lamotrigine levels do not exclude toxicity in cases of delirium.

Implications:

• Highlights the importance of careful medication management and monitoring for patients on lamotrigine.
• Suggests a need for increased clinical vigilance regarding potential drug interactions.
• Emphasizes that standard therapeutic drug monitoring may not always predict adverse events.